Wed, January 17, 2024

Douglas Tsao Maintained (APLS) at Strong Buy with Increased Target to $92 on, Jan 17th, 2024

Douglas Tsao of HC Wainwright & Co., Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Increased Target from $82 to $92 on, Jan 17th, 2024.

Douglas has made no other calls on APLS in the last 4 months.



There are 11 other peers that have a rating on APLS. Out of the 11 peers that are also analyzing APLS, 4 agree with Douglas's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $60 on, Friday, January 12th, 2024
  • Derek Archila of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $54 on, Thursday, December 14th, 2023
  • Graig Suvannavejh of "Mizuho" Initiated at Hold and Held Target at $42 on, Thursday, November 2nd, 2023
  • Brian Cheng of "B of A Securities" Maintained at Hold with Increased Target to $46 on, Thursday, October 12th, 2023


These are the ratings of the 7 analyists that currently disagree with Douglas


  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $106 on, Thursday, January 11th, 2024
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $90 on, Tuesday, January 9th, 2024
  • Justin Kim of "Oppenheimer" Maintained at Buy with Decreased Target to $75 on, Friday, December 15th, 2023
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $67 on, Friday, December 15th, 2023
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $56 on, Thursday, December 14th, 2023
  • Tazeen Ahmad of "B of A Securities" Upgraded from Hold to Strong Buy and Increased Target to $85 on, Tuesday, December 5th, 2023
  • Anupam Rama of "JP Morgan" Upgraded from Hold to Buy and Increased Target to $81 on, Friday, October 6th, 2023